Skip to Content

Avid Bioservices Inc CDMO

Morningstar Rating
$8.74 −0.09 (1.02%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CDMO is trading at a 630% premium.
Price
$8.72
Fair Value
$15.48
Uncertainty
Extreme
1-Star Price
$98.53
5-Star Price
$4.96
Economic Moat
Sfg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CDMO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$8.83
Day Range
$8.719.09
52-Week Range
$4.0717.39
Bid/Ask
$7.96 / $9.35
Market Cap
$554.81 Mil
Volume/Avg
388,724 / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
80.50
Price/Sales
4.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
365

Comparables

Valuation

Metric
CDMO
ACLX
EQRX
Price/Earnings (Normalized)
80.50
Price/Book Value
3.115.570.97
Price/Sales
4.0919.54
Price/Cash Flow
497.49382.81
Price/Earnings
CDMO
ACLX
EQRX

Financial Strength

Metric
CDMO
ACLX
EQRX
Quick Ratio
0.285.3218.43
Current Ratio
0.465.4618.78
Interest Coverage
−6.48−22.10
Quick Ratio
CDMO
ACLX
EQRX

Profitability

Metric
CDMO
ACLX
EQRX
Return on Assets (Normalized)
−1.88%−1.99%−15.72%
Return on Equity (Normalized)
−4.56%−3.75%−16.71%
Return on Invested Capital (Normalized)
−1.63%−7.24%−21.31%
Return on Assets
CDMO
ACLX
EQRX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRVxcylxqynKkss$605.7 Bil
VRTX
Vertex Pharmaceuticals IncCtfzcrkyJtjpwx$116.3 Bil
REGN
Regeneron Pharmaceuticals IncRdmwdtsKxkqzxn$108.5 Bil
MRNA
Moderna IncZdqxmxqCwp$62.9 Bil
BNTX
BioNTech SE ADRRrxygbdZkdtd$23.9 Bil
ARGX
argenx SE ADRMqjpnvfhZwzl$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncSklvctqzLpkzngz$18.9 Bil
BMRN
Biomarin Pharmaceutical IncWmpznghWpknvb$14.3 Bil
INCY
Incyte CorpTrkpfqmHytrfp$12.9 Bil
UTHR
United Therapeutics CorpBlstyhyRrhjf$12.1 Bil

Sponsor Center